Future Planet Capital

VC London, United Kingdom · Founded 2015

Future Planet Capital is an impact-led venture capital firm that invests in high-growth companies emerging from top universities and research ecosystems globally. They focus on profitably solving global challenges aligned with the UN Sustainable Development Goals, including climate change, education, health, security, and sustainable growth.

About Future Planet Capital

Future Planet Capital is a London-based venture firm with a thesis built around backing university-spinout businesses solving global challenges, with healthcare and life sciences as one of several focus areas alongside climate, education, and security. The futureplanetcapital.com website confirms a multi-stage platform with relationships into leading global universities and a public-mission flavor that emphasizes impact alongside financial return. For healthcare AI founders, Future Planet is a credible match for university-spinout businesses with strong scientific provenance, particularly those originating from Oxford, Cambridge, Imperial, or other top-tier global research institutions. Plausible check sizes run 500K to 5M at seed and Series A, with selective growth follow-on. The firm leads or co-leads in spinout rounds. Founders building healthcare AI as a university spinout with credible academic founders, IP from a research institution, and a clear translation path from research to commercial product should approach. Founders building healthcare AI without university research provenance, or businesses that are fundamentally execution-driven rather than science-led, will find the fit thinner; the firm’s edge is in academic and research network access. Entry path is through university tech transfer offices (Oxford Innovation, Cambridge Enterprise, Imperial Innovations are all in their orbit), LinkedIn outreach to partners with a clear academic provenance angle, or introduction through other university-focused investors. The firm responds to credible academic-origin pitches. Diligence will engage your academic advisors, scrutinize IP, and assess regulatory and clinical translation paths. The value-add is real for academic founders: navigating tech transfer, building scientific advisory boards, and accessing follow-on capital from impact-aligned investors.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by Future Planet Capital

Tools made by companies in Future Planet Capital's portfolio that we cover in the directory.

23andMe Personal Genome Service (PGS) Genetic Health Risk Test for Hereditary Thrombophilia
23andMe
Clinical Decision Support & Reference
The 23andMe Personal Genome Service (PGS) Genetic Health Risk Test for Hereditary Thrombophilia is an FDA-cleared direct-to-consumer genetic test that identifies specific genetic variants (Factor V Leiden and Prothrombin G20210A) associated with an increased risk of developing harmful blood clots. It provides personal genetic insights for proactive health discussions with healthcare professionals.
MedWiseRx
AnewHealth
Clinical Decision Support & Reference
MedWiseRx, powered by AnewHealth's MedWise technology, is an AI-driven clinical decision support tool that assesses multi-drug interactions, predicts adverse drug events, and optimizes medication regimens using pharmacogenomics, pharmacokinetics, and pharmacodynamics for patients with complex needs.

Portfolio companies in our directory

Other portfolio companies

Companies in Future Planet Capital's portfolio not currently in our directory.

  • Vaccitech (now Barinthus Biotherapeutics)
  • Ikarovec
  • Houdini Bio

Team

Douglas Hansen-Luke
Executive Chairman
Ed Phillips
Managing Director Global
Jessica Hill
Director of Investor Relations & Strategic Partnerships
Alex Leigh
Managing Director National
Surjit Kooner
Managing Director Regional
Lyle Pentith
Portfolio Manager
LinkedIn

Pitch / review this investor

Have you raised from Future Planet Capital? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.